KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for AbbVie (ABBV) over the last 15 years, with Q3 2025 value amounting to $1.8 billion.

  • AbbVie's Shares Outstanding (Weighted Average) changed 0.0% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.8 billion for FY2024, which is 5.66% up from last year.
  • According to the latest figures from Q3 2025, AbbVie's Shares Outstanding (Weighted Average) is $1.8 billion, which was down 0.0% from $1.8 billion recorded in Q2 2025.
  • AbbVie's 5-year Shares Outstanding (Weighted Average) high stood at $1.8 billion for Q1 2022, and its period low was $1.8 billion during Q2 2023.
  • For the 5-year period, AbbVie's Shares Outstanding (Weighted Average) averaged around $1.8 billion, with its median value being $1.8 billion (2021).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first skyrocketed by 1944.63% in 2021, then fell by 16.94% in 2023.
  • AbbVie's Shares Outstanding (Weighted Average) (Quarter) stood at $1.8 billion in 2021, then rose by 0.06% to $1.8 billion in 2022, then dropped by 0.17% to $1.8 billion in 2023, then rose by 0.06% to $1.8 billion in 2024, then changed by 0.0% to $1.8 billion in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $1.8 billion for Q3 2025, versus $1.8 billion for Q2 2025 and $1.8 billion for Q1 2025.